ACR适宜性标准® 尿路上皮癌治疗前分期:2024更新版
美国放射学会(ACR)适宜性标准基于证据和专家小组评审,将尿路上皮癌治疗前分期患者分为非肌层浸润性膀胱癌、肌层浸润性膀胱癌和上尿路尿路上皮癌三组,推荐相应影像学检查以评估局部和远处播散及同步上尿路和膀胱病灶。
要点
- 治疗前分期影像需评估肿瘤局部和远处播散,并排查上尿路及膀胱同步尿路上皮癌病灶。
- 患者分为非肌层浸润性膀胱癌、肌层浸润性膀胱癌和上尿路尿路上皮癌三组分别推荐检查。
- 推荐基于文献系统分析,采用GRADE和RAND/UCLA适宜性方法制定。
核心结论
- ACR适宜性标准为尿路上皮癌治疗前分期提供基于证据的影像学检查推荐,按非肌层浸润性膀胱癌、肌层浸润性膀胱癌和上尿路尿路上皮癌三组分层。
研究设计与样本
- 美国放射学会适宜性标准,由多学科专家小组每年审查,采用GRADE和RAND/UCLA适宜性方法系统分析同行评议文献,证据不足时可依据专家意见形成推荐。
局限性
- 在同行评议文献缺乏或模棱两可时,专家意见可能是形成推荐的主要证据来源。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Urothelial cancer is the second most common cancer, and cause of cancer death, related to the genitourinary tract. The goals of imaging for pretreatment staging of urothelial cancer are to evaluate for both local and distant spread of the cancer and assessing for synchronous sites of urothelial cancer in the upper tracts and bladder. For pretreatment staging of urothelial carcinoma, patients can be stratified into one of three groups: 1) nonmuscle invasive bladder cancer; 2) muscle invasive bladder cancer; and 3) upper urinary tract urothelial carcinoma. This document is a review of the current literature for urothelial cancer and resulting recommendations for pretreatment staging imaging. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision process support the systematic analysis of the medical literature from peer reviewed journals. Established methodology principles such as Grading of Recommendations Assessment, Development, and Evaluation or GRADE are adapted to evaluate the evidence. The RAND/UCLA Appropriateness Method User Manual provides the methodology to determine the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where peer reviewed literature is lacking or equivocal, experts may be the primary evidentiary source available to formulate a recommendation.
引用
- Barker SJ, Soylu E, Allen BC, et al. ACR Appropriateness Criteria® Pretreatment Staging of Urothelial Cancer: 2024 Update. J Am Coll Radiol. 2024. PMID: 39488355. doi:10.1016/j.jacr.2024.08.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。